Cillian King

Investment Manager
Swanbridge Capital

Cillian joined Swanbridge Capital in 2018 following a career in consultancy for early-stage ventures in the Life Sciences industry. As a consultant, Cillian gained extensive experience in the valuation of novel healthcare technologies, business development, project management, and non-dilutive funding.

In addition to working with early-stage ventures, Cillian was also involved in setting up several Dutch investment funds, including Swanbridge Capital in 2016. Cillian has a background in Molecular Biology (VU University and MIT) and a PhD in Molecular Neuroscience (VU University).

At Swanbridge Capital, Cillian is responsible for sourcing and evaluating investment proposals, deal making, and the management of portfolio companies.